154 related articles for article (PubMed ID: 31576111)
1. Design, Synthesis, And Evaluation Of Cyanopyridines As Anti-Colorectal Cancer Agents Via Inhibiting STAT3 Pathway.
Xu L; Shi L; Qiu S; Chen S; Lin M; Xiang Y; Zhao C; Zhu J; Shen L; Zuo Z
Drug Des Devel Ther; 2019; 13():3369-3381. PubMed ID: 31576111
[TBL] [Abstract][Full Text] [Related]
2. Structure-based discovery of potent and selective small-molecule inhibitors targeting signal transducer and activator of transcription 3 (STAT3).
Huang Q; Zhong Y; Li B; Ouyang S; Deng L; Mo J; Shi S; Lv N; Wu R; Liu P; Hu W; Zhang X; Wang Y
Eur J Med Chem; 2021 Oct; 221():113525. PubMed ID: 34000483
[TBL] [Abstract][Full Text] [Related]
3. LL1, a novel and highly selective STAT3 inhibitor, displays anti-colorectal cancer activities in vitro and in vivo.
Liu Z; Wang H; Guan L; Lai C; Yu W; Lai M
Br J Pharmacol; 2020 Jan; 177(2):298-313. PubMed ID: 31499589
[TBL] [Abstract][Full Text] [Related]
4. Anlotinib inhibits the progress of colorectal cancer cells by antagonizing VEGFR/JAK2/STAT3 axis.
Jia ZX; Zhang Z; Li Z; Li A; Xie YN; Wu HJ; Yang ZB; Zhang HM; Zhang XM
Eur Rev Med Pharmacol Sci; 2021 Mar; 25(5):2331-2343. PubMed ID: 33755971
[TBL] [Abstract][Full Text] [Related]
5. Effect of the isoflavone corylin from cullen corylifolium on colorectal cancer growth, by targeting the STAT3 signaling pathway.
Yang L; Yao Y; Bai Y; Zheng D; Zhou F; Chen L; Hu W; Xiang Y; Zhao H; Liu Z; Wang L; Huang X; Zhao C
Phytomedicine; 2021 Jan; 80():153366. PubMed ID: 33080566
[TBL] [Abstract][Full Text] [Related]
6. Novel imidazopyridine suppresses STAT3 activation by targeting SHP-1.
Su JC; Chang CH; Wu SH; Shiau CW
J Enzyme Inhib Med Chem; 2018 Dec; 33(1):1248-1255. PubMed ID: 30261753
[TBL] [Abstract][Full Text] [Related]
7. Aminocyanopyridines as anti-lung cancer agents by inhibiting the STAT3 pathway.
Xu L; Qiu S; Yang L; Xu H; Liu X; Fan S; Cui R; Fu W; Zhao C; Shen L; Wang L; Huang X
Mol Carcinog; 2019 Aug; 58(8):1512-1525. PubMed ID: 31069881
[TBL] [Abstract][Full Text] [Related]
8. Exploration of novel isoxazole-fused quinone derivatives as anti-colorectal cancer agents through inhibiting STAT3 and elevating ROS level.
Zhang L; Liu P; Jiang Y; Fan D; He X; Zhang J; Luo B; Sui J; Luo Y; Fu X; Yang T
Eur J Med Chem; 2024 Jun; 272():116448. PubMed ID: 38704936
[TBL] [Abstract][Full Text] [Related]
9. Apoptosis: A target for anticancer therapy with novel cyanopyridines.
Ismail MMF; Farrag AM; Harras MF; Ibrahim MH; Mehany ABM
Bioorg Chem; 2020 Jan; 94():103481. PubMed ID: 31837830
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and biological evaluation of celastrol derivatives as potent antitumor agents with STAT3 inhibition.
Xu S; Fan R; Wang L; He W; Ge H; Chen H; Xu W; Zhang J; Xu W; Feng Y; Fan Z
J Enzyme Inhib Med Chem; 2022 Dec; 37(1):236-251. PubMed ID: 34894961
[TBL] [Abstract][Full Text] [Related]
11. Utilization of cyanopyridine in design and synthesis of first-in-class anticancer dual acting PIM-1 kinase/HDAC inhibitors.
Bass AKA; Nageeb EM; El-Zoghbi MS; Mohamed MFA; Badr M; Abuo-Rahma GEA
Bioorg Chem; 2022 Feb; 119():105564. PubMed ID: 34959179
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis and activity of novel 2,6-disubstituted purine derivatives, potential small molecule inhibitors of signal transducer and activator of transcription 3.
Wang X; He Q; Wu K; Guo T; Du X; Zhang H; Fang L; Zheng N; Zhang Q; Ye F
Eur J Med Chem; 2019 Oct; 179():218-232. PubMed ID: 31254923
[TBL] [Abstract][Full Text] [Related]
13. Discovery of Novel 3-Cyanopyridines as Survivin Modulators and Apoptosis Inducers.
Sabour R; Harras MF; Mohamed Al Kamaly O; Altwaijry N
Molecules; 2020 Oct; 25(21):. PubMed ID: 33105831
[TBL] [Abstract][Full Text] [Related]
14. Palladium (II) Complex Enhances ROS-Dependent Apoptotic Effects via Autophagy Inhibition and Disruption of Multiple Signaling Pathways in Colorectal Cancer Cells.
Aydinlik S; Erkisa M; Ari F; Celikler S; Ulukaya E
Anticancer Agents Med Chem; 2021; 21(10):1284-1291. PubMed ID: 32990544
[TBL] [Abstract][Full Text] [Related]
15. Convallatoxin promotes apoptosis and inhibits proliferation and angiogenesis through crosstalk between JAK2/STAT3 (T705) and mTOR/STAT3 (S727) signaling pathways in colorectal cancer.
Zhang ZH; Li MY; Wang Z; Zuo HX; Wang JY; Xing Y; Jin C; Xu G; Piao L; Piao H; Ma J; Jin X
Phytomedicine; 2020 Mar; 68():153172. PubMed ID: 32004989
[TBL] [Abstract][Full Text] [Related]
16. The Natural-Based Antitumor Compound T21 Decreases Survivin Levels through Potent STAT3 Inhibition in Lung Cancer Models.
Martínez-García D; Pérez-Hernández M; Korrodi-Gregório L; Quesada R; Ramos R; Baixeras N; Pérez-Tomás R; Soto-Cerrato V
Biomolecules; 2019 Aug; 9(8):. PubMed ID: 31412593
[TBL] [Abstract][Full Text] [Related]
17. A Ferrocene Derivative Reduces Cisplatin Resistance in Breast Cancer Cells through Suppression of MDR-1 Expression and Modulation of JAK2/STAT3 Signaling Pathway.
Noori S; Nourbakhsh M; Farzaneh S; Zarghi A
Anticancer Agents Med Chem; 2020; 20(18):2285-2292. PubMed ID: 32767949
[TBL] [Abstract][Full Text] [Related]
18. Discovery of monocarbonyl curcumin-BTP hybrids as STAT3 inhibitors for drug-sensitive and drug-resistant breast cancer therapy.
Zhang W; Guo J; Li S; Ma T; Xu D; Han C; Liu F; Yu W; Kong L
Sci Rep; 2017 Apr; 7():46352. PubMed ID: 28397855
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis and biological evaluation of novel plumbagin derivatives as potent antitumor agents with STAT3 inhibition.
Li N; Ou J; Bao N; Chen C; Shi Z; Chen L; Sun J
Bioorg Chem; 2020 Nov; 104():104208. PubMed ID: 32919131
[TBL] [Abstract][Full Text] [Related]
20. A novel small molecular STAT3 inhibitor, 5Br-6b, induces apoptosis and inhibits migration in colorectal cancer cells.
Liu Z; Wang H; Guan L; Chen S; Lai M
Anticancer Drugs; 2018 Jun; 29(5):402-410. PubMed ID: 29438179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]